Search Results - Fram, R.J

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    239 Niraparib, a selective PARP 1/2 inhibitor, is efficacious in pre-clinical models of small-cell lung cancer

    239 Niraparib, a selective PARP 1/2 inhibitor, is efficacious in pre-clinical models of small-cell lung cancer by Wang, Y, Ricono, J, Admunson, K, Agarwal, S, Fram, R.J, Broudy, T, Wilcoxen, K.M

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    P1.23-01 ctDNA Positivity Is a Clinical Prognosis Biomarker in Patients with EGFR ex20ins+ NSCLC

    P1.23-01 ctDNA Positivity Is a Clinical Prognosis Biomarker in Patients with EGFR ex20ins+ NSCLC by Chatterjee, S., Tong, X., Su, Z., Li, Y., Guha, M., Churchill, E.N., Fram, R.J., Vincent, S.

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    P2.10-15 Correlation Between Clinical and Health-related Quality-of-Life (HRQoL) Benefits in Patients With ALK+ NSCLC in ALTA-1L

    P2.10-15 Correlation Between Clinical and Health-related Quality-of-Life (HRQoL) Benefits in Patients With ALK+ NSCLC in ALTA-1L by García-Campelo, R., Lin, H.M., Pérol, M., Jahanzeb, M., Szumski, A., Wu, Y., Geiger, A., Goodman, E., Fram, R.J., Popat, S., Camidge, D.R.

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Subasumstat, a first-in-class inhibitor of SUMO-activating enzyme, demonstrates dose-dependent target engagement and SUMOylation inhibition, leading to rapid activation of innate and adaptive immune responses in the dose escalation portion of a phase 1/2 clinical study

    Subasumstat, a first-in-class inhibitor of SUMO-activating enzyme, demonstrates dose-dependent target engagement and SUMOylation inhibition, leading to rapid activation of innate a... by Saggu, G., Stroopinsky, D., Dudek, A.Z., Olszanski, A.J., Juric, D., Dowlati, A., Vaishampayan, U., Assad, H., Rodón, J., Gibbs, J., Green, J., Du, Z., Rudicell, R., Kannan, K., Gharavi, R., Gomez-Pinillos, A., Fram, R.J., Berger, A., Sachsenmeier, K., Kasar, S.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    570 Phase 1 study of XMT-1001, a novel water soluble camptothecin conjugate, given as an IV infusion every 3 weeks to patients with advanced solid tumors

    570 Phase 1 study of XMT-1001, a novel water soluble camptothecin conjugate, given as an IV infusion every 3 weeks to patients with advanced solid tumors by Fram, R.J, Garbo, L.E, Weiss, G.J, Shkolny, D, Yurkovetskiy, A.V, Bethune, C, Ramanathan, R.K, Edelman, M.J, Sausville, E.A

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    649 POSTER Phase I trial of BB-10901 (huN901-DM1) given daily by IV infusion for three consecutive days every three weeks in patients with SCLC and other CD56-positive solid tumors

    649 POSTER Phase I trial of BB-10901 (huN901-DM1) given daily by IV infusion for three consecutive days every three weeks in patients with SCLC and other CD56-positive solid tumors by Lorigan, P., Woll, P.J., O'Brien, M., Fosella, F.V., Zildjian, S., Welch, S., Xie, H., Clinch, Y., Donaldson, K., Fram, R.J.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    212 POSTER A Phase I study of huC242-DM4 to assess the safety and pharmacokinetics of huC242-DM4 administered as a single intravenous infusion once every three weeks to subjects with solid tumors

    212 POSTER A Phase I study of huC242-DM4 to assess the safety and pharmacokinetics of huC242-DM4 administered as a single intravenous infusion once every three weeks to subjects wi... by Tolcher, A.W., Ricart, A., Rodon, J., Patnaik, A., Mita, A., Mita, M., Sarantopolus, S., Zildjian, S., Watermill, J., Fram, R.J.

    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Sequence specificity of streptozotocin-induced mutations

    Sequence specificity of streptozotocin-induced mutations by MACK, S. L, FRAM, R. J, MARINUS, M. G

    Published in Nucleic acids research
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: